Cardinal Health (NYSE: CAH), Dublin, OH, has completed the sale its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co, Ltd. for $1.2 billion. The sale was announced in November.
The sale includes Cardinal Health's pharmaceutical and medical products distribution business in China. The divestiture does not include Cardinal Health's remaining businesses in China, including Cordis, its recently acquired Patient Recovery business, its medical sourcing team or other functions.
Read the latest articles and see your reports.
The MDM update newsletter is your best source for news and trends in the wholesale distribution industry.
Join other distribution executives who use MDM Premium to optimize their business. Our insights and analysis help you enter the right new markets, turbocharge your sales and marketing efforts, identify business partners that help you scale, and stay ahead of your competitors.
By providing your email, you agree to receive announcements from us and our partners for our newsletter, events, surveys, and partner resources per MDM Terms & Conditions. You can withdraw consent at any time.
Wholesale distribution news and trends delivered right to your inbox.
Sign-up for our free newsletter and get:
